Statement of Changes in Beneficial Ownership (4)
December 02 2020 - 5:31PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Berge Terence M |
2. Issuer Name and Ticker or Trading Symbol
CONMED CORP
[
CNMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP-Corporate Controller |
(Last)
(First)
(Middle)
C/O CONMED CORPORATION, 525 FRENCH ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
11/30/2020 |
(Street)
UTICA, NY 13502
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 11/30/2020 | | S | | 2061 | D | $103.36 (1) | 8851 | D | |
Common Stock | 11/30/2020 | | M | | 3350 | A | $41.93 | 12201 | D | |
Common Stock | 11/30/2020 | | S | | 3350 | D | $103.4022 (2) | 8851 | D | |
Common Stock | 12/1/2020 | | S | | 2939 | D | $103.00 | 5912 | D | |
Common Stock | 12/1/2020 | | M | | 5050 | A | $41.93 | 10962 | D | |
Common Stock | 12/1/2020 | | S | | 5050 | D | $103.00 | 5912 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Options To Purchase Common Stock | $41.93 | 11/30/2020 | | M | | | 3350 | (3) | 3/1/2027 | Common Stock | 3350 | $0 | 10650 | D | |
Options To Purchase Common Stock | $41.93 | 12/1/2020 | | M | | | 5050 | (3) | 3/1/2027 | Common Stock | 5050 | $0 | 5600 | D | |
Explanation of Responses: |
(1) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.305 to $103.46. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
(2) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.26 to $103.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
(3) | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Berge Terence M C/O CONMED CORPORATION 525 FRENCH ROAD UTICA, NY 13502 |
|
| VP-Corporate Controller |
|
Signatures
|
/s/ Sarah M. Oliker for Terence M. Berge by Power of Attorney | | 12/2/2020 |
**Signature of Reporting Person | Date |
CONMED (NYSE:CNMD)
Historical Stock Chart
From May 2024 to Jun 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2023 to Jun 2024